$7.04
+0 (+0%)
At Close: Nov 14, 2025
Stock Market Today: S&P 500, Nasdaq 100 Futures Trade Mixed— UnitedHealth, 180 Life Sciences, Intel In Focus
05:55am, Friday, 15'th Aug 2025
U.S. stock futures were fluctuating on Friday following Thursday's mixed moves. Futures of major benchmark indices were mixed.
Palantir co-founder Peter Thiel buys into crypto firm as stock soars 250%
05:07am, Wednesday, 13'th Aug 2025
Shares of 180 Life Sciences Corp. (NASDAQ: ATNF) surged 206.59% on Tuesday to close at $10.24, after regulatory filings revealed that billionaire tech investor Peter Thiel had acquired a 7.5% stake in
180 Life Sciences (ETHZilla) Holds 82,186 ETH
08:00am, Tuesday, 12'th Aug 2025
Company Initiates Institutional ETH Accumulation Strategy PALO ALTO, Calif. , Aug. 12, 2025 /PRNewswire/ -- 180 Life Sciences Corp. (Nasdaq: ATNF), dba ETHZilla (the "Company", "180 Life Sciences" or
180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes
08:00am, Monday, 11'th Aug 2025
Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings This milestone follows the announcement of the Company's recently closed $425 million private
180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy
10:30pm, Monday, 04'th Aug 2025
Company intends to use the net proceeds from this financing primarily to rapidly increase its ETH holdings Company plans to execute a differentiated yield generation program, with Company built for th
180 Life Sciences announces entry into PIPE funding documents to raise $425 million in gross proceeds to launch next generation Ethereum treasury strategy and planned rebranding to ETHZilla PALO ALTO,
180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets
07:30am, Tuesday, 01'st Jul 2025
PALO ALTO, CA / ACCESS Newswire / July 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180" or the "Company), an innovative biotechnology company that is currently pivoting to the global iGaming sec
PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global iGamin
180 Life Sciences Corp. Announces Share Repurchase
08:30am, Wednesday, 30'th Apr 2025
PALO ALTO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences," the "Company," "we," or "us") today announced that it has entered into a Settleme
PALO ALTO, CA / ACCESSWIRE / December 27, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
08:00am, Thursday, 12'th Dec 2024
PALO ALTO, CA / ACCESSWIRE / December 12, 2024 / 180 Life Sciences Corp. ("180" or the "Company") is pleased to announce that it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requ
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
08:00am, Wednesday, 04'th Dec 2024
PALO ALTO, CA / ACCESSWIRE / December 4, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF), a biotechnology company that is currently refocusing its business on the international e
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
08:00am, Tuesday, 29'th Oct 2024
PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective i
PALO ALTO, CA / ACCESSWIRE / October 16, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF)("180" or the "Company"), today released the following letter to stockholders from its Interim Chief Executive Offi
180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
08:30am, Wednesday, 09'th Oct 2024
PALO ALTO, CA / ACCESSWIRE / October 9, 2024 / 180 Life Sciences Corp. (NASDAQ:ATNF) (the "Company" or "180"), is pleased to announce that it has received confirmation from Nasdaq that the Company has
Sign In
Buy ATNF